Literature DB >> 1980380

Systemic drug interactions with topical glaucoma medications.

S L Gerber1, L B Cantor, D C Brater.   

Abstract

Topically administered ophthalmic medications are capable of attaining clinically important serum concentrations, as evidenced by the variety of systemic side effects they can produce. These drugs are therefore also capable of interacting with other drugs administered orally and intravenously. This is especially important when medications are administered to an elderly population, who are often receiving multiple medications. The Physician's Desk Reference and the United States Pharmacopeia Drug Information directory contain numerous warnings of potential interactions between topical glaucoma medications and systemically administered drugs. Unfortunately, literature supporting such interactions is limited, both in quantity and quality, being anecdotal in many cases. This report summarizes available information regarding the nonocular interactions between topical ophthalmic glaucoma medications and other systemically administered medications. Clinical evidence of these interactions is lacking in many cases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980380     DOI: 10.1016/0039-6257(90)90090-i

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  7 in total

Review 1.  Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension.

Authors:  P Chrisp; E M Sorkin
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

Review 2.  Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.

Authors:  David C Broadway; Heidi Cate
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

Review 3.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

Review 4.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

5.  Prevalence of diabetes mellitus and hypertension among Indian glaucoma patients and evaluation of systemic therapy.

Authors:  Abhishek Dave; Shveta Jindal Bali; Reetika Sharma; Aruj K Khurana; Raghav Gupta; Tanuj Dada
Journal:  Int Ophthalmol       Date:  2013-02-14       Impact factor: 2.031

6.  Sick sinus syndrome associated with topical timolol maleate instillation.

Authors:  Harpreet S Walia; Sandeep S Walia; Matthew E Emanuel
Journal:  J Pharmacol Pharmacother       Date:  2011-10

7.  Management and outcome of topical beta-blocker-induced atrioventricular block.

Authors:  Kazim Serhan Özcan; Bariş Güngör; Damirbek Osmonov; Ahmet Ilker Tekkeşin; Servet Altay; Ahmet Ekmekçi; Ercan Toprak; Ersin Yildirim; Nazmi Çalik; Ahmet Taha Alper; Kadir Gürkan; Izzet Erdinler
Journal:  Cardiovasc J Afr       Date:  2015 Nov-Dec       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.